MHRA – December 2021 Licensing Time-based Performance Measures Published MHRA – December 2021 Licensing Time-based Performance Measures Published MHRA publish data on the expected time taken to process and... MHRA – December 2021 Licensing Time-based Performance Measures Published
Importing Medicines into Northern Ireland – MHRA Guidance Updated Importing Medicines into Northern Ireland – MHRA Guidance Updated The MHRA guidance ‘Importing medicines into Northern Ireland’ has been updated.The... Importing Medicines into Northern Ireland – MHRA Guidance Updated
MHRA Business Impact Target – NQRP Summary for 2020/21 MHRA Business Impact Target – NQRP Summary for 2020/21 The business impact target (BIT) is a cross-government target for the... MHRA Business Impact Target – NQRP Summary for 2020/21
EMA – Public Consultation on the Guideline on the Acceptability of Names for Human Medicinal Products Processed Through the Centralised Procedure EMA – Public Consultation on the Guideline on the Acceptability of Names for Human Medicinal Products Processed Through the Centralised... EMA – Public Consultation on the Guideline on the Acceptability of Names for Human Medicinal Products Processed Through the Centralised Procedure
Publication of Joint HMA-EMA Data Standardisation Strategy Publication of Joint HMA-EMA Data Standardisation Strategy The joint HMA-EMA Data Standardisation Strategy (DSS) has been published... Publication of Joint HMA-EMA Data Standardisation Strategy
MHRA Webinar – Hot Topics in Medicines Advertising MHRA Webinar – Hot Topics in Medicines Advertising 2022Date: Thursday 17 March 2022Time: 10:30am – 12:30amThis webinar will explore... MHRA Webinar – Hot Topics in Medicines Advertising
